Open AccessImprovement of Gut Diversity and Composition After Direct-Acting Antivirals in Hepatitis C Virus–Infected Patients With or Without Human Immunodeficiency Virus Coinfection
Author(s) -
Natthaya Chuaypen,
Thananya Jinato,
Anchalee Avihingsa,
Sakkarin Chirapongsathorn,
Supapon Cheevadhanarak,
Intawat Nookaew,
Yasuhito Tanaka,
Pisit Tangkijvanich
Publication year - 2021
Publication title -
the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.69
H-Index - 252
eISSN - 1537-6613
pISSN - 0022-1899
DOI - 10.1093/infdis/jiab094
Subject(s) - coinfection , dysbiosis , hepatitis c virus , microbiome , gut flora , virology , virus , immunology , medicine , microbiology and biotechnology , bacteroidetes , biology , bacteria , 16s ribosomal rna , bioinformatics , genetics
The influence of direct-acting antivirals (DAAs) on the composition of gut microbiota in hepatitis C virus (HCV)-infected patients with or without human immunodeficiency virus (HIV) is unclear.